Dynamic immune signatures as biomarkers for irAEs. Academic Article uri icon

abstract

  • Identifying predictive biomarkers of immune-related adverse events (irAEs) is crucial to maximize the benefits for patients with cancer treated with immune checkpoint inhibitors (ICIs). In a recent study published in Med,Nuez et al. utilized multi-omics approaches and identified blood immune signatures that have the potential to predict the development of autoimmune toxicity.

published proceedings

  • Trends Cancer

author list (cited authors)

  • Yang, J., Chen, Y., & Han, L.

complete list of authors

  • Yang, Jingwen||Chen, Yamei||Han, Leng

publication date

  • May 2023